PSNL
Personalis, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$16.40
+1.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 19.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.45x
- Price / sales
- 25.14x
- Price / cash flow
- -18.98x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 22.63x
- EV / EBITDA
- -16.22x
- EV / EBIT
- -13.79x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026